Fisher & Paykel Healthcare Corporation Limited (FRA:FPLB)

Market Cap	11.10B -3.1%
Revenue (ttm)	1.07B +14.2%
Net Income	215.98M +144.8%
EPS	0.37 +144.1%
Shares Out	n/a
PE Ratio	51.41
Forward PE	44.80
Dividend	n/a
Ex-Dividend Date	n/a

Volume	194
Average Volume	n/a
Open	18.80
Previous Close	18.30
Day's Range	18.80 - 18.80
52-Week Range	17.90 - 20.20
Beta	n/a
RSI	46.18
Earnings Date	Feb 27, 2026

About FRA:FPLB

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationally. It provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company also offers adult respiratory products, including airvo system, optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilatio...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 1934
• Employees: 7,412
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: FPLB

Financial Performance

In fiscal year 2025, FRA:FPLB's revenue was 2.02 billion, an increase of 15.96% compared to the previous year's 1.74 billion. Earnings were 377.20 million, an increase of 184.46%.

Financial numbers in NZD